These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 17416768)

  • 21. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.
    Decensi A; Johansson H; Miceli R; Mariani L; Camerini T; Cavadini E; Di Mauro MG; Barreca A; Gonzaga AG; Diani S; Sandri MT; De Palo G; Formelli F
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1047-53. PubMed ID: 11588130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
    Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.
    Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I, soy protein intake, and breast cancer risk.
    Sanderson M; Shu XO; Yu H; Dai Q; Malin AS; Gao YT; Zheng W
    Nutr Cancer; 2004; 50(1):8-15. PubMed ID: 15572292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.
    Renehan AG; Harvie M; Howell A
    Endocr Relat Cancer; 2006 Jun; 13(2):273-8. PubMed ID: 16728563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
    Jernström H; Deal C; Wilkin F; Chu W; Tao Y; Majeed N; Hudson T; Narod SA; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):377-84. PubMed ID: 11319179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
    Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body shape throughout life and correlations with IGFs and GH.
    Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.